• DOI:10.1038/nrc1649
Corpus ID: 10330140

The sweet and sour of cancer: glycans as novel therapeutic targets

@article{Fuster2005TheSA,
  title={The sweet and sour of cancer: glycans as novel therapeutic targets},
  author={M. Fuster and J. Esko},
  journal={Nature Reviews Cancer},
  year={2005},
  volume={5},
  pages={526-542}
}

M. Fuster, J. Esko

Published 2005

Biology, Medicine

Nature Reviews Cancer

View on Springer

eskolab.ucsd.edu

Save to Library

Create Alert

Cite

Launch Research Feed

A growing body of evidence supports crucial roles for glycans at various pathophysiological steps of tumour progression. Glycans regulate tumour proliferation, invasion, haematogenous metastasis and angiogenesis, and increased understanding of these roles sets the stage for developing pharmaceutical agents that target these molecules. Such novel agents might be used alone or in combination with operative and/or chemoradiation strategies for treating cancer.